In summary, the current data confirm that patients with type 1 diabetes may have high adiponectin levels, but whether lower levels of adiponectin are associated with insulin resistance or clinical cardiovascular disease cannot be confirmed. The gene discussed is ADIPOQ; the disease is cardiovascular disorder.